Long COVID: systemic inflammation and obesity as therapeutic targets

Lancet Respir Med. 2022 Aug;10(8):726-727. doi: 10.1016/S2213-2600(22)00159-X. Epub 2022 Apr 23.
No abstract available

Publication types

  • Comment

MeSH terms

  • COVID-19* / complications
  • Humans
  • Inflammation / drug therapy
  • Obesity / complications
  • Post-Acute COVID-19 Syndrome
  • SARS-CoV-2